Remove Advocacy Remove Clinical Trials Remove Data Remove Medicine
article thumbnail

These Patient Advocacy Groups Are Working Together to Expand the Scope of Cannabis Research

Veriheal

But one area of cannabis medicine is still lagging behind—research. states pass relevant legislation and educating doctors about the power of cannabis medicine. Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play.

article thumbnail

Medicinal cannabis users in the UK could be unfairly criminalised as study finds failures in roadside drug testing

Cannabis Law Report

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern. “We

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

South African Research Team Says Cannabis is ‘Very Promising’ as an Opioid Replacement

Veriheal

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. Quite frankly, the clinical trials couldn’t have come at a better time.

article thumbnail

Urge Kentucky Lawmakers to Support Medical Cannabis Reform Today!

NORML

It’s understandable lawmakers want reliable data before making a decision. The good news for Kentucky legislators is the data already i s available. National Library of Medicine has more than 26,000 published studies/reviews across 24 databases regarding cannabis available to read online. 8 – state Rep.

Data 187
article thumbnail

Study on MDMA for Traumatic Brain Injury Boosted By $1.5M Donation

SpeedWeed

Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. MAPS is pushing forward research on a number of psychedelics with potential in medicine. Fund associated research, administered by MAPS PBC, with additional capital.

article thumbnail

Press Release: Maya and National Psychedelics Association Announce Partnership to Support Psilocybin-Assisted Services in Oregon

Cannabis Law Report

The product suite includes a purpose-built Companion App for individuals, a Measurement Based Care Platform for providers, and a Real World Data Platform for both academic and commercial researchers. Through the right mix of regulation, technology, and data, both are equally achievable,” says NPA CEO Britt Rollins.

article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

These students showed knowledge and passion for the future of cannabis and posed revolutionary ideas rooted in their training across business, agriculture, biochemistry, public health, pharmacology, medicine, and liberal arts. . Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”.